How Has the Hematology Analyzers and Reagents Market Evolved Historically and What is its Current Size?
The hematology analyzers and reagents market has seen considerable growth due to a variety of factors.
• In previous years, the market size for hematology analyzers and reagents has experienced significant growth. It is anticipated to expand from $4.9 billion in 2024 to $5.25 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%.
This growth during the historic period is primarily due to an increase in chronic illnesses, an aging population, a rising burden of disease, and increased prevalence of infectious diseases.
What Is The Projected Growth Of The Hematology Analyzers and Reagents Template Market?
The hematology analyzers and reagents market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for hematology analyzers and reagents is projected to witness significant expansion in the coming years, growing to a value of $6.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%.
This growth over the forecast period can be linked to global health issues, increased investment in the infrastructure for hematology analyzer and reagent, customized healthcare, and the spread of remote monitoring. Key trends that will shape this market during the forecast period include technological advancements, testing methods with high sensitivity, molecular hematology testing, automation and integration, point-of-care testing (POCT), data analysis and artificial intelligence, not forgetting digital hematology.
What Are The Key Drivers Fueling Growth In The Hematology Analyzers and Reagents Market?
The escalation of infectious diseases is anticipated to propel the expansion of the hematology analyzers and reagents market. These diseases, which are instigated by harmful microorganisms such as bacteria, viruses, fungi, or parasites, have the potential to spread interpersonally or from the environment. A number of interconnected elements, including globalization which accelerates the spread of pathogens, antimicrobial resistance due to excessive antibiotic use, and social and economic conditions, are responsible for the increasing prevalence of infectious diseases. Hematology analyzers contribute to epidemiological research by providing data that allows public health officials to monitor outbreaks and understand the patterns of infectious disease transmission. For example, the Centers for Disease Control and Prevention reported in March 2024 that the count of tuberculosis cases escalated from 8,320 in 2022 to 9,615 in 2023, indicating an upliftment of 1,295 cases. Consequently, the escalated prevalence of infectious diseases is stimulating the growth of the hematology analyzer and reagent market.
What Are The Principal Market Segments In The Global Hematology Analyzers and Reagents Industry?
The hematology analyzers and reagents market covered in this report is segmented –
1) By Product: Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Slide Stainers, Differential Counters, Hematology Stains
2) By Applications: Anemias, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Other Applications
3) By End User: Specialized Research Institutes, Hospitals, Specialized Diagnostic Centers, Other End Users
Subsegments:
1) By Hematology Analyzers: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers
2) By Hemostasis Analyzers: Platelet Function Analyzers, Coagulation Testing Analyzers
3) By Plasma Protein Analyzers: Electrophoresis Analyzers, Immunofixation Analyzers
4) By Hemoglobin Analyzers: Point-Of-Care Hemoglobin Analyzers, Laboratory Hemoglobin Analyzers
5) By Erythrocyte Sedimentation Rate Analyzer: Manual ESR Analyzers, Automated ESR Analyzers
6) By Coagulation Analyzer: Clotting Time Analyzers, Thromboelastography (TEG) Analyzers
Pre-Book The Hematology Analyzers and Reagents Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Hematology Analyzers and Reagents Market?
The hematology analyzers and reagents market is being negatively impacted due to recalls of defective hematology analyzers. These recalls are initiated by the product manufacturer or creator when they detect safety concerns or defects that could harm the end user. Incorrect results may be delivered by a defective hematology analyzer, leading to possible misdiagnosis and thus, shaking consumers' trust in these analyzers. Regulatory bodies advise healthcare practitioners to be wary of the potential for inaccurate diagnostic outcomes with these tools and to employ suitable alternatives including manual scans or cell count estimations for result verification. For instance, problematic recalls have been witnessed in the cases of DxH800, DxH600, and DxH900 hematology analyzers by Beckman Coulter Life Sciences, due to the threat of inaccurate diagnostics. Recalls of this nature not only pose a severe public safety concern, they also risk significant financial loss and reputational damage for the involved companies.
Who Are the Key Players In The Hematology Analyzers and Reagents Market?
Major companies operating in the hematology analyzers and reagents market include:
• Abbott Laboratories
• Bio-Rad Laboratories
• Horiba Ltd.
• Siemens AG
• Sysmex Corporation
• BioSystems Diagnostics Pvt. Ltd
• Boule Diagnostics
• Danaher Corporation
• Diatron MI PLC
• Drew Scientific
• EKF Diagnostics
• Mindray
• Nihon Kohden
• Ortho Clinical Diagnostics
• Roche
• Beckman Coulter
• Bayer AG
• Heska
• Drucker
• Instrumentation Laboratory
• Abaxis Inc.
• Accriva Diagnostics
• ACON
• Diamond Diagnostics
• ERBA Diagnostics
• Hycel
• Maccura Biotechnology Co. Ltd.
• Genrui Biotech Inc.
• A&T Corporation
• Beijing Succeeder Technology Inc.
• Diagnostica Stago SAS
What Are The Regional Insights Into The Hematology Analyzers and Reagents Market?
North America was the largest region in the hematology analyzers and reagents market in 2024. Western Europe was the second-largest region in the hematology analyzers and reagents market report. The regions covered in the hematology analyzers and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
